ICH-GCP (R3) enters into force in Canada and China on April 1st and in the UK on April 28!

ICH-GCP (R3) enters into force in Canada and China on April 1st and in the UK on April 28!

by TRREE Team -
Number of replies: 0

Dear TRREE Users,

We would like to inform you that the updated ICH-GCP E6(R3) Guideline will come into effect in Canada and China on April 1, and in the UK on April 28, marking a key milestone in the evolution of clinical trial regulation worldwide.

With its stronger focus on quality by design, proportionality, and participant protection, the new guideline reflects how clinical research is adapting to more complex and data-driven environments.

For all those involved in clinical trials this is an important moment to engage with the updated framework and its practical implications. For this reason, the ICH-GCP training offered through TRREE’s Module 4R3 is particularly relevant.

We thank you again for your continuous endeavour to respect research ethics and wish you an insightful training.

TRREE Team